Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01422486 |
|
Recruitment Status :
Terminated
(Study TLK199.2107 was terminated for business reasons.)
First Posted : August 24, 2011
Last Update Posted : November 25, 2013
|
Sponsor:
Telik
Information provided by (Responsible Party):
Telik
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | February 2013 |
| Actual Study Completion Date : | February 2013 |